Wayne Kuznar
Wayne Kuznar is a contributor to Urology Times.
Long-term TRT improves urinary, erectile function
Long-term testosterone therapy in hypogonadal men improves urinary function and erectile function compared with untreated controls, according to registry data from a single practice.
Slow breathing technique helps reduce hot flashes
A slow breathing technique guided by an iOS application was able to reduce the occurrence of vasomotor symptoms in a small study of prostate cancer survivors treated with androgen deprivation therapy.
Convective water vapor ablation successful at 2 years
A treatment system that uses steam to ablate prostate tissue (Rezūm, NxThera, Inc.) can be considered as a first-line therapy for the treatment of lower urinary tract symptoms secondary to BPH, say investigators from a non-randomized multicenter pilot study with 2-year duration of successful outcomes.
Using mpMRI, 27% of men could avoid prostate biopsy
Multiparametric magnetic resonance imaging (mpMRI) identifies a significant percentage of men who present with an elevated serum PSA level who may safely avoid prostate biopsy, British researchers report.
Basic Science Research: Trimodal therapy shows promise in oligometastatic PCa
Other basic science research pearls include preliminary evidence from a porcine model suggesting botulinum toxin type A facilitates ureteral stone passage and the identification of two different microdeletions in the NELL1 gene on chromosome 11 in men with Peyronie's disease.
Long-term TRT use reduces risk of CV events, PCa
There is no excess risk of death, prostate cancer diagnosis, or cardiovascular events with long-term testosterone replacement therapy, Canadian researchers have found in a population-based matched cohort study.
Infection/Inflammation: A new class of agents for IC shows promise
Analyses of the urinary and gut microbiomes and a quality improvement to standardize use of antibiotics after prostate biopsy were among other AUA 2016 highlights in this therapeutic area.
Infertility/Andrology: Are vasectomy and prostate Ca linked?
Microdissection testicular sperm extraction retrieval rates, adolescent varicocele repair, and evaluation of testosterone replacement therapy and prostate cancer are additional noteworthy topics in this field.
Prostate Ca: PSA drop, active surveillance are key themes
Fusion biopsy, salvage versus adjuvant radiation therapy, and superextended versus extended pelvic lymph node dissection are also covered in the take home messages on prostate cancer from the 2016 AUA annual meeting.
Assay predicts outcomes in men taking mCRPC agent
Expression of androgen receptor splice variant 7 (AR-V7) in whole blood predicts worse cancer-related outcomes in patients with metastatic castration-resistant prostate cancer who are treated with abiraterone acetate (ZYTIGA).